Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-668-9 | CAS number: 70546-25-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Macrolex Fluoreszenzrot G was tested in a recent bacterial reverse gene mutation assay (Ames Test according to OECD TG 471) and considered to be mutagenic in the presence of S9 under the conditions of this test. There were no biologically significant increases in revertant colony frequency noted to any of the bacterial strains in the absence of S9-mix, however the test item induced statistically significant and dose-related increases in the frequency of TA100, TA98 and TA1537 revertant colonies from 5 µg/plate (TA98), 500 µg/plate (TA100) and 1500 µg/plate (TA1537). Smaller increases were also noted for TA1535 at 5000 µg/plate. The increases observed in the presence of S9-mix for TA100 and TA98 at the upper test item dose levels were particularly large and very much in excess of the maxima untreated/vehicle control in‑house historical ranges for the relevant bacterial strains with a maximum increase of 31.2 times over the concurrent vehicle control noted for TA98 at 5000 µg/plate. Any excursions outside the maxima ranges, particularly when a dose-response relationship is apparent, must be considered to be evidence of a biological response. A weaker statistically significant response was also noted to TA100 dosed in the absence of S9-mix at 50 µg/plate, however these counts were within the in-house untreated/vehicle historical control profile for the strain and showed no evidence of a dose-response relationship
In another bacterial reverse mutation assay with limited documentation Macrolex Fluoreszenzrot G was found to be not mutagenic either with or without exogenous metabolic activation at the dose levels investigated.
A potential alert for “in vitro mutagenicity (Ames) by ISS” was identified by the OECD Toolbox QSAR assessment; “Aromatic mono- and dialkylamine” and “Coumarins and Fucocoumarins”.
A test proposal for an in vivo Comet test according to OECD Guidelines for Testing of Chemicals No. 489 “In vivo Mammalian Alkaline Comet Assay” is included in the dossier to further investigate potential in vivo mutagenicity.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental start date: 05 July 2017 Experimental completion date: 18 September 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- Appearance: Olive green powder
Storage Conditions: Room temperature, in the dark
Expiry Date: 24 April 2020
Formulated concentrations were adjusted to allow for the stated water/impurity content of the test item. - Target gene:
- Histidine locus in S. typhimurium and tryptophan locus in E.coli.
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- a liver microsomal preparation (S9-mix) prepared from rats
- Test concentrations with justification for top dose:
- Experiment 1 - Plate Incorporation Method
The maximum concentration was 5000 µg/plate (the maximum recommended dose level).
Eight concentrations of the test item (1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate) were tested - Vehicle / solvent:
- The test item was insoluble in sterile distilled water, dimethyl sulphoxide, dimethyl formamide and acetonitrile at 50 mg/mL, acetone at 100 mg/mL and tetrahydrofuran at 200 mg/mL in solubility checks performed in–house. The test item formed the best doseable suspension in dimethyl sulphoxide, therefore, this solvent was selected as the vehicle.
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 2 µg/plate for WP2uvrA, 3 µg/plate for TA100, 5 µg/plate for TA1535
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- Absence of S9-mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 80 µg/plate for TA1537
- Positive control substance:
- 9-aminoacridine
- Remarks:
- Absence of S9-mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 0.2 µg/plate for TA98
- Positive control substance:
- other: 4-Nitroquinoline-1-oxide
- Remarks:
- Absence of S9-mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 1 µg/plate for TA100, 2 µg/plate for TA1535 and TA1537, 10 µg/plate WP2uvrA
- Positive control substance:
- other: 2-Aminoanthracene
- Remarks:
- Presence of S9-mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 5 µg/plate for TA98
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- Presence of S9-mix
- Details on test system and experimental conditions:
- Experimental Design and Study Conduct
Test Item Preparation and Analysis
The test item was accurately weighed and, on the day of the experiment, approximate half-log dilutions prepared in dimethyl sulphoxide by mixing on a vortex and sonication for 20 minutes at 40 °C. Formulated concentrations were adjusted to allow for the stated water/impurity content (2.4%) of the test item. All formulations were used within four hours of preparation and were assumed to be stable for this period. Homogeneity/stability analysis was performed outside the confines of this study under Envigo Research Limited project number WX02TH for a low dose (0.1 mg/mL) and a high dose (200 mg/mL). Analysis for concentration of the test item formulations is not a requirement of the test guidelines and was, therefore, not determined. This is an exception with regard to GLP and has been reflected in the GLP compliance statement.
Test for Mutagenicity: Experiment 1 - Plate Incorporation Method
Eight concentrations of the test item were assayed in triplicate against each tester strain, using the direct plate incorporation method.
Without Metabolic Activation
0.1 mL of the appropriate concentration of test item, solvent vehicle or appropriate positive control was added to 2 mL of molten, trace amino-acid supplemented media containing 0.1 mL of one of the bacterial strain cultures and 0.5 mL of phosphate buffer. These were then mixed and overlayed onto a Vogel Bonner agar plate. Negative (untreated) controls were also performed on the same day as the mutation test. Each concentration of the test item, appropriate positive, vehicle and negative controls, and each bacterial strain, was assayed using triplicate plates.
With Metabolic Activation
The procedure was the same as described previously except that following the addition of the test item formulation and bacterial culture, 0.5 mL of S9 mix was added to the molten, trace amino-acid supplemented media instead of phosphate buffer.
Incubation and Scoring
All of the plates were incubated at 37 ± 3 ºC for approximately 48 hours and scored for the presence of revertant colonies using an automated colony counting system. The plates were viewed microscopically for evidence of thinning (toxicity). Several manual counts were required due to revertant colonies spreading slightly, thus distorting the actual plate count.
Test for Mutagenicity: Experiment 2
The second experiment was not performed because the OECD 471 test guideline permits non repetition of the experiment when a clear, positive response is obtained in the first experiment. Therefore, a second, confirmatory experiment was not required. - Evaluation criteria:
- There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested (De Serres and Shelby, 1979).
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. Statistical analysis of data as determined by UKEMS (Mahon et al., 1989).
5. Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out of historical range response (Cariello and Piegorsch, 1996)).
A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met.
Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit making a definite judgment about test item activity. Results of this type will be reported as equivocal. - Statistics:
- Statistical significance was confirmed by using Dunnetts Regression Analysis (* = p < 0.05) for those values that indicate statistically significant increases in the frequency of revertant colonies compared to the concurrent solvent control.
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Remarks:
- at 5000 µg/plate
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Remarks:
- from 1500 µg/plate
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Remarks:
- from 5 µg/plate
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Remarks:
- from 500 µg/plate
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Prior to use, the master strains were checked for characteristics, viability and spontaneous reversion rate (all were found to be satisfactory). The amino acid supplemented top agar and the S9-mix used in both experiments was shown to be sterile. The test item formulation was also shown to be sterile. These data are not given in the report.
Results for the negative controls (spontaneous mutation rates) were considered to be acceptable. These data are for concurrent untreated control plates performed on the same day as the Mutation Test.
The vehicle (dimethyl sulphoxide) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
The maximum dose level of the test item in the first experiment was selected as the maximum recommended dose level of 5000 µg/plate. There was no visible reduction in the growth of the bacterial background lawn at any dose level, either in the presence or absence of metabolic activation (S9-mix), in the first mutation test (plate incorporation method).
A red test item induced colouration was initially noted at 15 µg/plate becoming dark green/grey at 5000 µg/plate. A test item particulate precipitate was also noted at 5000 µg/plate. None of these observations prevented the scoring of revertant colonies.
There were no biologically significant increases in revertant colony frequency noted to any of the bacterial strains in the absence of S9-mix, however the test item induced statistically significant and dose-related increases in the frequency of TA100, TA98 and TA1537 revertant colonies from 5 µg/plate (TA98), 500 µg/plate (TA100) and 1500 µg/plate (TA1537). Smaller increases were also noted for TA1535 at 5000 µg/plate. The increases observed in the presence of S9-mix for TA100 and TA98 at the upper test item dose levels were particularly large and very much in excess of the maxima untreated/vehicle control in house historical ranges for the relevant bacterial strains with a maximum increase of 31.2 times over the concurrent vehicle control noted for TA98 at 5000 µg/plate. Any excursions outside the maxima ranges, particularly when a dose-response relationship is apparent, must be considered to be evidence of a biological response. A weaker statistically significant response was also noted to TA100 dosed in the absence of S9-mix at 50 µg/plate, however these counts were within the in-house untreated/vehicle historical control profile for the strain and showed no evidence of a dose-response relationship. - Conclusions:
- Macrolex Fluoreszenzrot G was considered to be mutagenic under the conditions of this test.
- Executive summary:
Introduction
The test method was designed to be compatible with the guidelines for bacterial mutagenicity testing published by the major Japanese Regulatory Authorities including METI, MHLW and MAFF, the OECD Guidelines for Testing of Chemicals No. 471 "Bacterial Reverse Mutation Test", Method B13/14 of Commission Regulation (EC) number 440/2008 of 30 May 2008 and the USA, EPA OCSPP harmonized guideline - Bacterial Reverse Mutation Test.
Methods
Salmonella typhimuriumstrains TA1535, TA1537, TA98 and TA100 and Escherichia coli strain WP2uvrA were treated with the test item using the Ames plate incorporation method at eight dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolizing system (10% liver S9 in standard co-factors). The dose range for Experiment 1 was predetermined and was 1.5 to 5000 mg/plate.
The OECD 471 test guideline permits non-repetition of the experiment when a clear positive response is obtained in the first experiment, therefore, with the Sponsor’s approval, testing was suspended at the end of Experiment 1.
Results
The vehicle (dimethyl sulphoxide) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
The maximum dose level of the test item in the first experiment was selected as the maximum recommended dose level of 5000 µg/plate. There was no visible reduction in the growth of the bacterial background lawn at any dose level, either in the presence or absence of metabolic activation (S9-mix), in the first mutation test (plate incorporation method).
A red test item induced colouration was initially noted at 15 µg/plate becoming dark green/grey at 5000 µg/plate. A test item particulate precipitate was also noted at 5000 µg/plate. None of these observations prevented the scoring of revertant colonies.
There were no biologically significant increases in revertant colony frequency noted to any of the bacterial strains in the absence of S9-mix, however the test item induced statistically significant and dose-related increases in the frequency of TA100, TA98 and TA1537 revertant colonies from 5 µg/plate (TA98), 500 µg/plate (TA100) and 1500 µg/plate (TA1537). Smaller increases were also noted for TA1535 at 5000 µg/plate. The increases observed in the presence of S9-mix for TA100 and TA98 at the upper test item dose levels were particularly large and very much in excess of the maxima untreated/vehicle control in‑house historical ranges for the relevant bacterial strains with a maximum increase of 31.2 times over the concurrent vehicle control noted for TA98 at 5000 µg/plate. Any excursions outside the maxima ranges, particularly when a dose-response relationship is apparent, must be considered to be evidence of a biological response. A weaker statistically significant response was also noted to TA100 dosed in the absence of S9-mix at 50 µg/plate, however these counts were within the in-house untreated/vehicle historical control profile for the strain and showed no evidence of a dose-response relationship.
Conclusion
Macrolex Fluoreszenzrot G was considered to be mutagenic under the conditions of this test.
Reference
Spontaneous Mutation Rates (Concurrent Negative Controls)
Experiment 1
Number of revertants (mean number of colonies per plate) |
|||||||||
Base-pair substitution type |
Frameshift type |
||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
|||||
111 |
|
15 |
|
24 |
|
36 |
|
10 |
|
103 |
(104) |
21 |
(21) |
17 |
(20) |
30 |
(37) |
19 |
(14) |
98 |
|
26 |
|
19 |
|
45 |
|
12 |
|
Test Results: Experiment 1 – Without Metabolic Activation (Plate Incorporation)
Test Period |
From: 15 September 2017 |
To: 18 September 2017 |
||||||||||
S9-Mix (-) |
Dose Level Per Plate |
Number of revertants (mean) +/- SD |
||||||||||
Base-pair substitution strains |
Frameshift strains |
|||||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||||||||
Solvent Control (DMSO) |
82 81 90 |
(84) 4.9# |
23 20 26 |
(23) 3.0 |
20 21 25 |
(22) 2.6 |
27 36 44 |
(36) 8.5 |
18 19 22 |
(20) 2.1 |
||
1.5 µg |
88 82 79 |
(83) 4.6 |
23 26 24 |
(24) 1.5 |
17 29 19 |
(22) 6.4 |
42 37 29 |
(36) 6.6 |
12 16 15 |
(14) 2.1 |
||
5 µg |
92 109 97 |
(99) 8.7 |
27 17 24 |
(23) 5.1 |
17 20 21 |
(19) 2.1 |
29 39 38 |
(35) 5.5 |
15 9 16 |
(13) 3.8 |
||
15 µg |
94 96 88 |
(93) 4.2 |
22 26 32 |
(27) 5.0 |
18 21 18 |
(19) 1.7 |
39 37 33 |
(36) 3.1 |
18 19 22 |
(20) 2.1 |
||
50 µg |
115 87 119 |
* (107) 17.4 |
35 28 31 |
(31) 3.5 |
18 20 17 |
(18) 1.5 |
44 32 29 |
(35) 7.9 |
22 11 21 |
(18) 6.1 |
||
150 µg |
89 107 96 |
(97) 9.1 |
30 30 35 |
(32) 2.9 |
18 16 14 |
(16) 2.0 |
29 33 38 |
(33) 4.5 |
18 14 20 |
(17) 3.1 |
||
500 µg |
99 92 119 |
(103) 14.0 |
34 35 23 |
(31) 6.7 |
20 19 19 |
(19) 0.6 |
38 33 29 |
(33) 4.5 |
24 17 8 |
(16) 8.0 |
||
1500 µg |
114 82 89 |
(95) 16.8 |
19 31 20 |
(23) 6.7 |
16 21 13 |
(17) 4.0 |
29 30 30 |
(30) 0.6 |
20 17 18 |
(18) 1.5 |
||
5000 µg |
95 P 83 P 88 P |
(89) 6.0 |
29 P 24 P 31 P |
(28) 3.6 |
13 P 16 P 18 P |
(16) 2.5 |
32 P 32 P 33 P |
(32) 0.6 |
15 P 16 P 15 P |
(15) 0.6 |
||
Positive controls S9-Mix (-) |
Name Dose Level No. of Revertants |
ENNG |
ENNG |
ENNG |
4NQO |
9AA |
||||||
3 µg |
5 µg |
2 µg |
0.2 µg |
80 µg |
||||||||
561 584 657 |
(601) 50.1 |
677 722 709 |
(703) 23.2 |
772 781 867 |
(807) 52.4 |
202 195 225 |
(207) 15.7 |
281 364 389 |
(345) 56.5 |
|||
ENNG N-ethyl-N'-nitro-N-nitrosoguanidine
4NQO 4-Nitroquinoline-1-oxide
9AA 9-Aminoacridine
P Test item precipitate
* p ≤ 0.05
# Standard deviation
Test Results: Experiment 1 – With Metabolic Activation (Plate Incorporation)
Test Period |
From: 15 September 2017 |
To: 18 September 2017 |
||||||||||
S9-Mix (+) |
Dose Level Per Plate |
Number of revertants (mean) +/- SD |
||||||||||
Base-pair substitution strains |
Frameshift strains |
|||||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||||||||
Solvent Control (DMSO) |
89 75 80 |
(81) 7.1# |
21 33 21 |
(25) 6.9 |
32 33 37 |
(34) 2.6 |
37 37 37 |
(37) 0.0 |
22 9 16 |
(16) 6.5 |
||
1.5 µg |
87 72 92 |
(84) 10.4 |
25 23 25 |
(24) 1.2 |
39 25 29 |
(31) 7.2 |
39 58 54 |
(50) 10.0 |
6 24 9 |
(13) 9.6 |
||
5 µg |
82 92 82 |
(85) 5.8 |
26 34 29 |
(30) 4.0 |
18 26 25 |
(23) 4.4 |
61 79 57 |
*** (66) 11.7 |
15 17 16 |
(16) 1.0 |
||
15 µg |
83 93 96 |
(91) 6.8 |
28 34 24 |
(29) 5.0 |
30 30 21 |
(27) 5.2 |
57 62 57 |
** (59) 2.9 |
15 10 21 |
(15) 5.5 |
||
50 µg |
104 77 80 |
(87) 14.8 |
34 27 34 |
(32) 4.0 |
19 24 26 |
(23) 3.6 |
81 63 73 |
*** (72) 9.0 |
25 16 31 |
(24) 7.5 |
||
150 µg |
95 94 110 |
(100) 9.0 |
30 34 36 |
(33) 3.1 |
28 20 22 |
(23) 4.2 |
100 100 96 |
*** (99) 2.3 |
14 26 21 |
(20) 6.0 |
||
500 µg |
112 101 113 |
** (109) 6.7 |
29 31 26 |
(29) 2.5 |
27 22 29 |
(26) 3.6 |
211 204 201 |
*** (205) 5.1 |
30 28 28 |
(29) 1.2 |
||
1500 µg |
167 194 199 |
*** (187) 17.2 |
32 40 27 |
(33) 6.6 |
32 26 31 |
(30) 3.2 |
635 644 673 |
*** (651) 19.9 |
33 45 33 |
** (37) 6.9 |
||
5000 µg |
346 P 339 P 361 P |
*** (349) 11.2 |
44 P 34 P 38 P |
** (39) 5.0 |
21 P 25 P 25 P |
(24) 2.3 |
1198 P 1161 P 1102 P |
*** (1154) 48.4 |
46 P 42 P 51 P |
*** (46) 4.5 |
||
Positive controls S9-Mix (+) |
Name Dose Level No. of Revertants |
2AA |
2AA |
2AA |
BP |
2AA |
||||||
1 µg |
2 µg |
10 µg |
5 µg |
2 µg |
||||||||
2345 2457 2297 |
(2366) 82.1 |
219 361 387 |
(322) 90.4 |
544 569 589 |
(567) 22.5 |
386 393 393 |
(391) 4.0 |
586 648 571 |
(602) 40.8 |
|||
2AA 2-Aminoanthracene
BP Benzo(a)pyrene
P Precipitate
** p ≤ 0.01
*** p ≤ 0.001
# Standard deviation
Additional information
Justification for classification or non-classification
Macrolex Fluoreszenzrot G was tested in a recent bacterial reverse gene mutation assay (Ames Test according to OECD TG 471) and considered to be mutagenic in the presence of S9 under the conditions of this test. In another bacterial reverse mutation assay with limited documentation Macrolex Fluoreszenz Rot G was found to be not mutagenic either with or without exogenous metabolic activation at the dose levels investigated. A potential alert for “in vitro mutagenicity (Ames) by ISS” was identified by the OECD Toolbox QSAR assessment; “Aromatic mono- and dialkylamine” and “Coumarins and Fucocoumarins”.
A test proposal for an in vivo Comet test according to OECD Guidelines for Testing of Chemicals No. 489 “In vivo Mammalian Alkaline Comet Assay” is included in the dossier to further investigate potential in vivo mutagenicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.